Ly6C expression differentiates plasma cells from other B cell subsets in mice

Area of Science:

• Immunology
• Cell Biology

Background:

• Plasma cell differentiation is crucial for adaptive immunity.
• Lipopolysaccharide (LPS) and anti-CD40 antibodies are key inducers of B cell activation and plasma cell differentiation.
• The specific markers of B cell activation and plasma cell differentiation are not fully elucidated.

Purpose of the Study:

• To identify novel cell surface markers associated with B cell activation and plasma cell differentiation.
• To investigate the role of the Ly6C protein in B cell responses to LPS stimulation.
• To determine the expression pattern of Ly6C on plasma cells in vivo and in vitro.

Main Methods:

• Subtractive cDNA hybridization was employed to identify differentially expressed genes.
• Flow cytometry and magnetic-activated cell sorting (MACS) were used for cell analysis and sorting.
• ELISPOT assays were performed to quantify antibody-secreting cells.
• In vitro cell culture systems were utilized to study B cell activation and differentiation.

Main Results:

• The cell surface protein Ly6C was identified as differentially expressed on B cells stimulated with LPS but not with anti-CD40 antibodies.
• Ly6C expression was found to be up-regulated on B cells following LPS stimulation in vitro, an effect blocked by anti-CD40 or anti-Ig antibodies.
• Ly6C was confirmed to be expressed on ex vivo plasma cells from spleen and bone marrow, as well as on splenic and lamina propria plasma cells.
• Cross-linking of Ly6C on LPS-stimulated splenic B cells in vitro led to increased immunoglobulin production.

Conclusions:

• Ly6C is a novel marker for activated B cells and plasma cells.
• Ly6C expression is regulated by LPS and immunoglobulin signaling pathways during B cell activation.
• Ly6C plays a functional role in enhancing immunoglobulin production by plasma cells.